Zepbound vs Mounjaro Cost Comparison 2026: Same Drug, Different Price

Same Drug, Two Brand Names

Before comparing costs, the most important thing to understand: Zepbound and Mounjaro are pharmacologically identical. Both contain tirzepatide as the active ingredient, both are manufactured by Eli Lilly, both use the same KwikPen autoinjector, and both come in identical dose strengths (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg).

The only difference is the FDA label. Eli Lilly markets tirzepatide under two brand names because the FDA approves drugs for specific medical conditions — and insurance coverage follows those approvals. Mounjaro launched in May 2022 for type 2 diabetes. Zepbound launched in November 2023 for chronic weight management (and later received an additional approval for obstructive sleep apnea).

Clinically, there is no reason to prefer one over the other. The molecule, dosing, side effects, and weight loss results are identical. The decision between them is purely about insurance coverage and cost.

Retail List Price Comparison

At retail, the price difference is negligible — about $6/month. Nobody should choose between these drugs based on list price. The real cost difference comes from insurance coverage, manufacturer programs, and whether you consider the compounded alternative.

Insurance Coverage: Which Is Cheaper?

This is where the two brands diverge dramatically.

If you have type 2 diabetes

Mounjaro wins. Insurance plans consistently cover diabetes medications, and Mounjaro's FDA approval for type 2 diabetes means it's on most commercial formularies. With a Mounjaro savings card and commercial insurance coverage, many patients pay as little as $25/month.

If you want weight loss (no diabetes)

Zepbound is the on-label option, but insurance coverage for weight loss medications is inconsistent. Some employer plans cover Zepbound; many don't. Medicare does not cover any GLP-1 for weight loss by statute (though legislative proposals are in progress). If your plan doesn't cover Zepbound, you're looking at self-pay pricing.

If you have obstructive sleep apnea

Zepbound has a unique advantage. It received FDA approval for moderate-to-severe obstructive sleep apnea in adults with obesity — the first medication ever approved specifically for sleep apnea treatment. This opens a new insurance coverage pathway that Mounjaro doesn't have.

Savings Cards & LillyDirect

Mounjaro Savings Card

Available to commercially insured patients with a type 2 diabetes diagnosis. Can reduce cost to as low as $25/month for eligible patients. Annual savings cap applies (~$1,950/year maximum). Patients on government insurance (Medicare, Medicaid, Tricare) are not eligible.

Zepbound Savings Card

Available to commercially insured patients. Can reduce cost to as low as $25/month if your plan covers Zepbound. For patients whose insurance doesn't cover Zepbound, a smaller discount may apply (up to ~$463 off per fill). Same government insurance exclusions apply.

LillyDirect (Zepbound Only)

This is the game-changer for self-pay patients. Eli Lilly's direct-to-consumer program sells Zepbound single-dose vials (not prefilled pens — you draw the dose with a syringe) at dramatically reduced pricing:

LillyDirect is Zepbound-only — there's no equivalent program for Mounjaro, because diabetes patients more frequently have insurance coverage. This makes Zepbound the clear winner for uninsured self-pay patients who want a brand-name product.

The Compounded Option: Why It's Cheaper

For patients who find both brand-name options too expensive, compounded tirzepatide from a licensed 503A or 503B pharmacy offers the same active ingredient at a fraction of the cost — typically $130–$300/month depending on the provider and dose.

Compounded tirzepatide uses pharmaceutical-grade active ingredient but is prepared by a compounding pharmacy rather than Eli Lilly's manufacturing facilities. It comes in multi-dose vials (you draw the dose yourself) rather than prefilled pens.

The annual savings between compounded tirzepatide and brand-name retail can exceed $10,000. Even compared to LillyDirect, compounded options save $2,000–$3,800/year at typical pricing.

Compounded Tirzepatide Providers

If you're considering compounded tirzepatide, here are verified providers with current pricing:

Which Is Actually Cheaper for You?

Here's how to figure out your cheapest path to tirzepatide:

Scenario 1: You have type 2 diabetes + commercial insurance

→ Mounjaro is likely cheapest. Apply for the Mounjaro Savings Card. Many patients pay $25/month. Check your plan's formulary first.

Scenario 2: You want weight loss + commercial insurance covers Zepbound

→ Zepbound with savings card. As low as $25/month with eligible coverage. Confirm coverage with your insurer before filling.

Scenario 3: You want weight loss + no insurance coverage

→ Compounded tirzepatide is cheapest ($130–$300/month). LillyDirect Zepbound vials ($299–$449/month) are the cheapest brand-name option. Choose based on your comfort level with compounded vs. brand-name.

Scenario 4: You have Medicare

→ Mounjaro may be covered if you have type 2 diabetes (through Part D). Medicare does not cover GLP-1 medications for weight loss. For weight loss, your options are LillyDirect self-pay or compounded tirzepatide.

Scenario 5: You have sleep apnea + obesity

→ Zepbound has a unique coverage pathway. It's the only tirzepatide product FDA-approved for obstructive sleep apnea. Insurance coverage for this indication is expanding. Get a sleep study and prescribe for OSA specifically.

Frequently Asked Questions

Is Zepbound cheaper than Mounjaro?

At retail, they cost nearly the same (~$1,080/month). However, Zepbound is cheaper for uninsured self-pay patients because of the LillyDirect program ($299–$449/month for vials). Mounjaro is typically cheaper for patients with type 2 diabetes and insurance coverage.

Why is semaglutide cheaper than tirzepatide?

Compounded semaglutide is generally $130–$200/month while compounded tirzepatide is $199–$300/month. The price difference reflects tirzepatide's newer patent status, higher API costs, and the dual-mechanism formulation. Brand-name Wegovy and Ozempic have similar retail pricing to Mounjaro and Zepbound.

Can I switch between Zepbound and Mounjaro?

Yes, switching is seamless since the active ingredient is identical. Your prescriber writes a new prescription for the other brand at the same dose. No transition period, dose adjustment, or clinical risk involved.

Is compounded tirzepatide the same as Zepbound?

The active ingredient (tirzepatide) is the same. The difference is that compounded tirzepatide is prepared by a licensed compounding pharmacy, not manufactured by Eli Lilly. It comes in vials rather than prefilled pens and is not FDA-approved as a finished product. The regulatory pathway and quality controls differ, but the molecule is identical.

Which is better for weight loss — Zepbound or Mounjaro?

Neither is "better" — they're the same medication. The SURMOUNT trials showing ~20.9% average body weight loss at the maximum dose apply to both. Choose based on cost and insurance coverage, not clinical effectiveness.